{
  "ticker": "NUVB",
  "company_name": "Nuvation Bio Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06841874",
      "title": "Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC",
      "status": "NO_LONGER_AVAILABLE",
      "phase": "",
      "condition": "Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases, Respiratory Tract Diseases, Carcinoma, Bronchogenic Carcinoma, Non Small Cell Carcinoma of the Lung, ROS1-positive Non-Small Cell Lung Cancer (NSCLC)",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT05252390",
      "title": "NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer, Cancer of Ovary, Cancer of the Ovary, Ovary Neoplasm, Pancreatic Cancer, Pancreas Cancer, Cancer of Pancreas, Cancer of the Pancreas, Pancreas Neoplasm, Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration Resistant Prostatic Cancer, Castration Resistant Prostatic Neoplasms, Triple-negative Breast Cancer, Triple Negative Breast Cancer, Triple Negative Breast Neoplasms, Breast Cancer, Breast Carcinoma, Cancer of Breast, Cancer of the Breast, Breast Tumor",
      "start_date": "2022-03-29",
      "completion_date": "2024-07-15",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT04541225",
      "title": "Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Glioma, Glioma, Malignant, Glioma, Mixed, Glial Cell Tumors, Breast Cancer, Breast Carcinoma, Cancer of Breast, Cancer of the Breast, Breast Tumor, Malignant Tumor of Breast, Advanced Breast Cancer, Advanced Breast Carcinoma, Metastatic Breast Cancer, Metastatic Breast Carcinoma, Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration-resistant Prostate Cancer, Castration Resistant Prostatic Neoplasms, Glioblastoma, Recurrent Glioblastoma",
      "start_date": "2020-12-08",
      "completion_date": "2022-08-31",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT05357820",
      "title": "A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Solid Tumor",
      "start_date": "2021-07-19",
      "completion_date": "2021-12-03",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT05191017",
      "title": "Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC",
      "status": "WITHDRAWN",
      "phase": "PHASE1, PHASE2",
      "condition": "Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration Resistant Prostatic Cancer, Castration Resistant Prostatic Neoplasms",
      "start_date": "2022-09",
      "completion_date": "2026-07",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT04919811",
      "title": "Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Non Small Cell Lung Cancer",
      "start_date": "2021-09-01",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT05191004",
      "title": "Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC",
      "status": "WITHDRAWN",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Breast Carcinoma, Cancer of the Breast, Cancer of Breast, Malignant Tumor of Breast, Breast Tumor",
      "start_date": "2022-09",
      "completion_date": "2026-09",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT02279433",
      "title": "A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Solid Tumors",
      "start_date": "2014-09",
      "completion_date": "2019-03",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT05357911",
      "title": "A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Solid Tumor",
      "start_date": "2021-07-13",
      "completion_date": "2021-12-03",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    },
    {
      "nct_id": "NCT06564324",
      "title": "A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Non Small Cell Lung Cancer",
      "start_date": "2024-11-27",
      "completion_date": "2030-09",
      "enrollment": 0,
      "sponsor": "Nuvation Bio Inc."
    }
  ],
  "summary": {
    "total_trials": 16,
    "by_phase": {
      "": 2,
      "PHASE1": 6,
      "PHASE1, PHASE2": 3,
      "PHASE2": 2,
      "PHASE3": 3
    },
    "by_status": {
      "NO_LONGER_AVAILABLE": 1,
      "TERMINATED": 3,
      "COMPLETED": 4,
      "WITHDRAWN": 2,
      "ACTIVE_NOT_RECRUITING": 2,
      "RECRUITING": 4
    },
    "active_trials": 6,
    "completed_trials": 4,
    "conditions": [
      "Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Breast Carcinoma, Cancer of the Breast, Cancer of Breast, Malignant Tumor of Breast, Breast Tumor",
      "Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC), Pancreatic Cancer, Platinum-resistant Ovarian Cancer (PROC)",
      "Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer, Cancer of Ovary, Cancer of the Ovary, Ovary Neoplasm, Pancreatic Cancer, Pancreas Cancer, Cancer of Pancreas, Cancer of the Pancreas, Pancreas Neoplasm, Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration Resistant Prostatic Cancer, Castration Resistant Prostatic Neoplasms, Triple-negative Breast Cancer, Triple Negative Breast Cancer, Triple Negative Breast Neoplasms, Breast Cancer, Breast Carcinoma, Cancer of Breast, Cancer of the Breast, Breast Tumor",
      "Cancer, Malignancies Multiple, Malignant Solid Tumor, Cancer, Therapy-Related, Molecular Sequence Variation, Genetic Alteration, Gene Fusion, Receptor Tyrosine Kinase Gene Mutation, RTK Family Gene Mutation, Ras (Kras or Nras) Gene Mutation",
      "Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, IDH-Mutant, Grade 2, Oligodendroglioma, Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",
      "Glioma, Glioma, Malignant, Glioma, Mixed, Glial Cell Tumors, Breast Cancer, Breast Carcinoma, Cancer of Breast, Cancer of the Breast, Breast Tumor, Malignant Tumor of Breast, Advanced Breast Cancer, Advanced Breast Carcinoma, Metastatic Breast Cancer, Metastatic Breast Carcinoma, Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration-resistant Prostate Cancer, Castration Resistant Prostatic Neoplasms, Glioblastoma, Recurrent Glioblastoma",
      "Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases, Respiratory Tract Diseases, Carcinoma, Bronchogenic Carcinoma, Non Small Cell Carcinoma of the Lung, ROS1-positive Non-Small Cell Lung Cancer (NSCLC)",
      "Non Small Cell Lung Cancer",
      "Non-small Cell Lung Cancer (NSCLC)",
      "Pharmacokinetic Study",
      "Prostate Cancer, Prostatic Cancer, Cancer of Prostate, Cancer of the Prostate, Prostate Neoplasm, Castrate Resistant Prostate Cancer, Castration Resistant Prostatic Cancer, Castration Resistant Prostatic Neoplasms",
      "Solid Tumor",
      "Solid Tumors"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:23.691147",
    "search_query": "Nuvation Bio Inc.",
    "url": "https://clinicaltrials.gov/search?term=Nuvation+Bio+Inc."
  }
}